Skip to main content

Peer Review reports

From: Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19

Original Submission
11 Jun 2022 Submitted Original manuscript
14 Dec 2022 Reviewed Reviewer Report - Mary-Theresa Usuanlele
14 Dec 2022 Reviewed Reviewer Report - Nixon Niyonzima
15 Dec 2022 Reviewed Reviewer Report - Stephen Noorduyn
19 Mar 2023 Author responded Author comments - Mohammad Ahmadvand
Resubmission - Version 2
19 Mar 2023 Submitted Manuscript version 2
30 Mar 2023 Reviewed Reviewer Report - Mary-Theresa Usuanlele
11 Apr 2023 Reviewed Reviewer Report - Nixon Niyonzima
15 Jun 2023 Author responded Author comments - Mohammad Ahmadvand
Resubmission - Version 3
15 Jun 2023 Submitted Manuscript version 3
Publishing
16 Jun 2023 Editorially accepted
4 Aug 2023 Article published 10.1186/s40814-023-01355-6

You can find further information about peer review here.

Back to article page